Stacey IvanchukDirector, Intellectual Property
Stacey has over 10 years experience relating to intellectual property (IP) protection, management and strategy. She oversees and provides strategic advice for all projects in Toronto Innovation Acceleration’s portfolio spanning diverse technical fields, working closely with the venture development teams to evaluate technologies and develop optimal IP protection strategies. In addition to her IP role, she is responsible for strategic oversight of all technologies originating from Baycrest, a TIAP member.
Prior to TIAP, Stacey was IP manager at Topigen Pharmaceuticals Inc., a Montreal-based biotechnology company (acquired by Pharmaxis Ltd.) where she provided IP-related strategic guidance including portfolio management, budgeting and financial forecasting. She was also formerly IP consultant at Baycrest where she identified and assessed commercial opportunities arising from neurocognitive research. In her role as Scientific Advisor in the IP group of Ogilvy Renault (now Norton Rose Fulbright), she gained experience drafting and prosecuting patent applications, focusing on life sciences/biotechnology patent protection.
Stacey received her B.Sc., Honours (Biology) and M.Sc. in cancer genetics from Queen’s University and her Ph.D. in molecular biology from the University of Toronto.